Physician profile
Thomas Michael Fields
NPI 1346443900
$1,712.69
in general payments reported to CMS, 2019-2025
33 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $356 · 2023: $433 · 2024: $314 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $224.82 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $170.90 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $157.33 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $137.69 | 2022-2025 | |
| Genentech USA, INC. | $106.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.68 | 2023-2025 | Jardiance, Tradjenta, Synjardy |
| Cmp Pharma, INC. | $83.79 | 2022 | |
| Exact Sciences Corporation | $75.11 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $61.47 | 2021-2025 | |
| Baxter Healthcare | $61.00 | 2022 | |
| Amgen INC. | $43.72 | 2023-2025 | Repatha, Otezla, Prolia |
| Abiomed | $43.34 | 2024 | Impella |
| Stryker Corporation | $40.10 | 2021 | |
| Corcept Therapeutics | $34.54 | 2024 | Korlym |
| Otsuka America Pharmaceutical, INC. | $34.02 | 2022-2023 | Rexulti |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.68 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $27.84 | 2024 | Airsupra |
| Mylan Specialty L.P. | $26.79 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.87 | 2022 | |
| Dexcom, INC. | $20.62 | 2024 | Dexcom G6 Transmitter |
| Electromed, INC. | $19.48 | 2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $19.34 | 2023 | |
| Antares Pharma, INC. | $18.93 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.43 | 2024 | |
| Amarin Pharma, INC. | $18.27 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.80 | 2023 | Quviviq |
| Astellas Pharma US INC | $17.73 | 2021 | |
| Depuy Synthes Sales INC. | $16.78 | 2023 | Peak, Orthovisc |
| Eisai INC. | $16.48 | 2021 | |
| Averitas Pharma INC. | $16.23 | 2023 | Qutenza |
| Sanofi-Aventis U.S. LLC | $14.46 | 2022 | |
| Spinal Simplicity, LLC | $13.90 | 2025 | Ha Minuteman G3-R |
| Amneal Pharmaceuticals LLC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.